Substance P and mast cells: Preliminary histologic analysis of the human temporomandibular joint

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 92, Issue 4, 2001, Pages 384-389

  Henry, Charles H ^b   Wolford, Larry M ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUBSTANCE P;

ADULT; ARTERY; ARTICLE; DISLOCATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INNERVATION; MAST CELL; MIDDLE AGED; NEUROGENIC INFLAMMATION; PATHOLOGY; SECRETION; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; VASCULARIZATION;

ADULT; ARTERIES; DISLOCATIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; MIDDLE AGED; NEUROGENIC INFLAMMATION; SUBSTANCE P; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 0035486951     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.117811     Document Type: Article

References (42)

1. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218-21.
2. Said SI. Neuropeptides as modulators of injury and inflammation. Life Sci 1990;47:19-21.
3. Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J. Calcitonin gene-related peptide, neurokinin A and substance P: Effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 1991;12:333-7.
4. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992;49:693-8.
5. Kido MA, Kiyoshima T, Kondo T, Ayasaka N, Moroi R, Terada Y, et al. Distribution of substance P and calcitonin gene-related peptide-like immunoreactive nerve fibers in the rat temporomandibular joint. J Dent Res 1993;72:592-8.
6. Ichikawa H, Wakisaka S, Matsuo S, Akai M. Peptidergic innervation of the temporomandibular disk in the rat. Experientia 1989;303-4.
7. Johansson A, Isacsson G, Isberg A, Granholm A. Distribution of substance P-like immunoreactive nerve fibers in temporomandibular joint soft tissues of monkey. Scand J Dent Res 1986;94:225-32.
8. Holmlund A, Ekblom A, Hansson P, Lind J, Lundeberg T, Theodorsson E. Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic findings. Int J Oral Maxillofacial Surg 1991;20:228-31.
9. Kopp S. The influence of neuropeptides, serotonin, and Interleukin 1β on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg 1998;56:189-91.
10. Appelgren A, Appelgren B, Eriksson S, Kopp S, Lundeberg T, Nylander M, et al. Neuropeptides in temporomandibular joints with rheumatoid arthritis: a clinical study. Scand J Dent Res 1991;99:519-21.
11. Harrison SD, Hukkanen M, Polak JM, Harris M. Immunolocalization of neuropeptides in the TMJ capsule. J Dent Res (Divisional Abstracts:British Division #344) 1993;72:729.
12. Franco P, Talwar R, Medina D. Substance P levels in hyperplastic retrodiscal tissues of patients with degenerative temporomandibular joint disease. J Oral Maxillofac Surg (Supplement 1, Poster 26) 1999;57:116.
13. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 1994;15:533-8.
14. McKay DM, Djuric VJ, Perdue MH, Bienenstock J. In: Heatly RV, editor. Gastrointestinal and hepatic immunology. Cambridge (UK): Cambridge University Press; 1995. p. 48-75.
15. Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg VI, et al. Enhancement of phagocytosis-a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 1980;94:1445-51.
16. Hukkanen M, Grönblad M, Rees R, Kottinen YT, Gibson SJ, Hietanen J, et al. Regional distribution of mast cells and peptide containing nerves in normal and adjuvant arthritic rat synovium. J Rheumatol 1991;18:177-83.
17. Dijkgraaf LC, de Bont LG, Boering G, Liem RS. Structure of the normal synovial membrane of the temporomandibular joint: A review of the literature. J Oral Maxillofac Surg 1996;54:332-8.
18. Carraway RE, Cochrane DE, Granier C, Kitabgi P, Leeman E, Singer EA. Parallel secretion of endogenous 5-hydroxytryptamine and histamine from mast cells stimulated by vasoactive peptides and compound 48/80. Br J Pharmacol 1984;81:227-9.
19. Bisset GW, Lewis GP. A spectrum of pharmacological activity in some biologically active peptides. Br J Pharmacol 1962;19:168-73.
20. Taiwo YO, Levine JD. Serotonin is a directly acting hyperalgesic agent in the rat. Neuroscience 1992;48:485-90.
21. Dines KC, Powell HC. Mast cell interactions with the nervous system: Relationship to mechanisms of disease. J Neuropathol Exp Neurol 1997;56:627-40.
22. Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK, Lehman KA, et al. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 1997;48:501-5.
23. Henry CH, Hudson AP, Gérard HC, Franco PF, Wolford LM. Identification of Chlamydia trachomatis in the human temporomandibular joint. J Oral Maxillofac Surg 1999;57:683-8.
24. Schumacher HR Jr. How micro-organisms are handled to localize to joints and within joints. Scand J Rheumatol Suppl 1995;101:199-202.
25. Henry CH, Hughes CV, Gérard HC, Hudson AP, Wolford LM. Reactive arthritis: Preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg 2000;58:1137-42.
26. Henry CH, Hughes CV, Babae R, Hudson AP, Wolford LM. Bacteria associated with reactive arthritis and the temporomandibular joint. Presented at the AAOMS 81st Annual Meeting Boston, MA, September 29-Oct 2, 1999.
27. Henry CH, Hughes CV, Hudson AP, Wolford LM. Identification of bacteria associated with reactive arthritis in the human temporomandibular joint. Presented at the 14th International Conference on Oral and Maxillofacial Surgery, Washington, DC, April 24-29, 1999. Int J Oral Maxillofac Surg 1999;28(Suppl 1):19.
28. Hughes CV, Henry CH, Majzner RG, Gérard HC, Hudson AP, Wolford LM. Mycoplasma genitalium and Mycoplasma fermentans in the human temporomandibular joint [abstract]. J Dent Res (Abstract# 2509) 1999;78:419.
29. Fu K, Ma X, Zhang Z, Chen W. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 1995;53:424-6.
30. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami KI. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998;56:192-8.
31. Sandler NA, Buckley MJ, Cillo JE, Braun TW. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxillofac Surg 1998;56:534-43.
32. Nordahl S, Alstergren P, Kopp S. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J Oral Maxillofac Surg 2000;58:525-30.
33. Perdue MH, Masson S, Wershil BK, Galli SJ. Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation. J Clin Invest 1991;87:687-93.
34. 4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg 1990;48:968-71.
35. 2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg 2000;58:180-6.
36. Dijkgraaf LC, Liem RS, de Bont LG. Ultrastructural characteristics of the synovial membrane in osteoarthritic temporomandibular joints. J Oral Maxillofac Surg 1997;55:1269-79.
37. Keat A, Thomas B, Hughes R, Taylor-Robinson D. Chlamydia trachomatis in reactive arthritis. Rheumatol Int 1989;9:197-200.
38. Kingsley G, Sieper J. Current perspectives in reactive arthritis. Immunol Today 1993;14:387-91.
39. Rahman MU, Cheema MA, Schumacher HR, Hudson AP. Molecular evidence for the presence of Chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 1992;35:521-9.
40. Taylor-Robinson D, Gilroy CB, Thomas BJ, Keat AC. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992;340:81-2.
41. Hammer M, Nettelnbreker E, Hopf S, Schmitz E, Porschke K, Zeidler H. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis. Clin Exp Rheumatol 1992;10:63-6.
42. Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: A proposed hypothesis. J Oral Maxillofac Surg 1998;56:214-23.